Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on November 14, 2005

Circulation. 2005
Published online before print November 14, 2005, doi: 10.1161/CIRCULATIONAHA.105.541714
A more recent version of this article appeared on November 22, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/21/3328    most recent
CIRCULATIONAHA.105.541714v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sales, V. L.
Right arrow Articles by Pratt, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sales, V. L.
Right arrow Articles by Pratt, R. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Remodeling
Right arrow ACE/Angiotension receptors
Right arrow Gene expression
Right arrow Genetically altered mice

Submitted on February 8, 2005
Revised on August 1, 2005
Accepted on September 12, 2005

Angiotensin Type 2 Receptor Is Expressed in Murine Atherosclerotic Lesions and Modulates Lesion Evolution

Virna L. Sales MD*, Galina K. Sukhova PhD, Marco A. Lopez-Ilasaca MD, PhD, Peter Libby MD, Victor J. Dzau MD, and Richard E. Pratt PhD

From the Cardiovascular Division (V.L.S., M.A.L.-I., V.J.D., R.E.P.) and Donald W. Reynolds Cardiovascular Clinical Research Center (G.K.S., P.L.), Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass. Dr Sales is now at the Department of Cardiac Surgery, Children’s Hospital Boston, Harvard Medical School, Boston, Mass; Dr Dzau is now at the Office of the Chancellor, Duke University Medical Center, Durham, NC.

* To whom correspondence should be addressed. E-mail: virna.sales{at}childrens.harvard.edu.

Background--In the vasculature, the angiotensin type 2 (AT2) receptor (AT2R) exerts antiproliferative, antifibrotic, and proapoptotic effects. Normal adult animals have low AT2R expression; however, vascular injury and exposure to proinflammatory cytokines augment AT2R levels. We hypothesized that AT2R expression increases during initiation and progression of atherosclerosis.

Methods and Results--Atherosclerotic lesions of apolipoprotein (Apo) E-/- mice contained AT2Rs, measured by real-time polymerase chain reaction and confirmed by immunohistochemistry. To test the consequences of this expression, male ApoE-/-, angiotensin II type 2 receptor-deficient (Agtr2-), and ApoE-/-, wild-type (Agtr2+) mice consumed a high-cholesterol diet from 4 weeks of age. Ten weeks later, overall area and cellular composition of aortic arch lesions did not differ significantly among genotypes. After 16 weeks, ApoE-/-/Agtr2+, but not ApoE-/-/Agtr2- mice had dramatic decreases in percent positive area of macrophages, smooth muscles, lipids, and collagen. Diminished bromodeoxyuridine incorporation and increased TUNEL staining accompanied these decreases.

Conclusions--Thus, loss of AT2R during the evolution of atherosclerotic lesions augmented the extent of cellularity of atherosclerotic lesions, establishing AT2R as a modulator of atherogenesis.


Key words: angiotensin • atherosclerosis • inflammation • receptors • renin




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
S. Lacchini, A. S. Heimann, F. S. Evangelista, L. Cardoso, G. J. J. Silva, and J. E. Krieger
Cuff-induced vascular intima thickening is influenced by titration of the Ace gene in mice
Physiol Genomics, May 13, 2009; 37(3): 225 - 230.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Nagai, Y. Oike, K. Izumi-Nagai, T. Urano, Y. Kubota, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, T. Suda, et al.
Angiotensin II Type 1 Receptor-Mediated Inflammation Is Required for Choroidal Neovascularization
Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2252 - 2259.
[Abstract] [Full Text] [PDF]